1428-67-7
1428-67-7 結構式
基本信息
SC-4473
Diarylpropionitrile
2,3-bis(p-hydroxyphenyl)propionitrile
2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE
propionitrile,2,3-bis(p-hydroxyphenyl)
2,3-Bis(4-hydroxyphenyl)propanenitrile
2,3-Bis(4-hydroxyphenyl)propiononitrile
2,3-Bis(4-hydroxyphenyl)propionitrile >
Benzenepropanenitrile, 4-hydroxy-α-(4-hydroxyphenyl)-
物理化學性質
安全數(shù)據(jù)
| 報價日期 | 產品編號 | 產品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/06 | B4385 | 2,3-雙(4-羥苯基)丙腈 2,3-Bis(4-hydroxyphenyl)propionitrile | 1428-67-7 | 10mg | 190元 |
| 2026/06/06 | B4385 | 2,3-雙(4-羥苯基)丙腈 2,3-Bis(4-hydroxyphenyl)propionitrile | 1428-67-7 | 50mg | 880元 |
| 2026/06/05 | HY-12452R | 2,3-雙(4-羥苯基)丙腈 DPN (Standard) | 1428-67-7 | 5 mg | 1100元 |
常見問題列表
|
ERβ 0.85 nM (EC 50 ) |
DPN has a 70-fold ERα relative binding affinity selectivity, and it is a full ERα agonist with a 78-fold ERα potency selectivity (EC
50
=0.85 nM for ERβ; EC
50
=66 nM for ERα).
DPN (10 nM) prevents morphological alterations from Aβ
1-42
(10 μM)-induced toxicity in cultured cortical neurons.
DPN (0.1-100 nM) decreases ROS levels in a non-dose response manner.
DPN (0.1-100 nM) significantly reduces Aβ
1-42
-stimulated expression of Bax in a non-dose dependent manner.
DPN (0.1-100 nM) reduces activated IL-1 levels induced by Aβ
1-42
treatment on cultured cortical neurons.
DPN (0.1-100 nM) suppresses the Aβ
1-42
-upregulated phosphorylation of JNK and p38.
DPN (10 μg; s.c.; daily; for 11 days) increases swimming and decreases immobility in the FST, and increases TPH protein expression in the dorsal raphe nucleus (DR) in rat model.
| Animal Model: | Adult Sprague-Dawley female rats (220-250 g), ovariectomized animal models |
| Dosage: | 10 μg/rat |
| Administration: | Subcutaneous injections, daily, for 11 days |
| Result: | Increased swimming and decreased immobility in the FST. |